← back to dashboard

SBFM

Sunshine Biopharma Inc.
Composite
0.07
EDGAR
0.07
Filings (90d)
5
Peak
0.08
Last Signal
2026-09-11T17:00

All Filings

Filed Form Items Signal Score Summary Link
2026-09-11 17:00 8-K ["8.01"] other 0.05 Item 8.01 disclosure regarding warrant exercise price adjustment due to ATM offering activity; no M&A signals. SEC · detail
2026-08-28 16:05 8-K ["5.02"] officer change 0.15 Director departure at end of term; routine governance event with no M&A indicators. SEC · detail
2026-08-03 08:52 8-K ["8.01"] other 0.05 Routine warrant exercise price adjustment due to at-the-market offering; no M&A signal. SEC · detail
2026-07-20 16:27 8-K ["1.01", "9.01"] other 0.05 ATM equity offering agreement with Aegis Capital; routine capital raise unrelated to M&A. SEC · detail
2026-07-10 16:54 8-K ["1.01", "9.01"] other 0.05 Settlement agreement with former executive; no M&A relevance. SEC · detail
2026-05-29 16:05 8-K ["5.07"] other 0.05 8-K Item 5.07 reports shareholder consent for warrant adjustments and share issuance—routine corporate governance, no M&A signal. SEC · detail
2026-05-19 16:05 8-K ["1.01", "8.01", "9.01"] other 0.05 Routine public offering with placement agent; no M&A signals present. SEC · detail